Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Market Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Latin America
6.2 By Country
7 Industry Opportunities and Challenges
8 Latin America Antifungal Drugs Market Analysis
8.1 Key Industry Highlights
8.2 Latin America Antifungal Drugs Historical Market (2019-2025)
8.3 Latin America Antifungal Drugs Market Forecast (2026-2035)
8.4 Latin America Antifungal Drugs Market by Drug Class
8.4.1 Azoles
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2019-2025)
8.4.1.3 Forecast Trend (2026-2035)
8.4.1.4 Breakup by Type
8.4.1.4.1 Voriconazole
8.4.1.4.2 Posaconazole
8.4.1.4.3 Isavuconazole (CRESEMBA)
8.4.1.4.4 Others
8.4.2 Echinocandins
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2019-2025)
8.4.2.3 Forecast Trend (2026-2035)
8.4.2.4 Breakup by Type
8.4.2.4.1 Caspofungin
8.4.2.4.2 Micafungin (Mycamine/ Funguard)
8.4.2.4.3 Others
8.4.3 Polyenes
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2019-2025)
8.4.3.3 Forecast Trend (2026-2035)
8.4.3.4 Breakup by Type
8.4.3.4.1 Amphotericin (AmBisome)
8.4.3.4.2 Others
8.4.4 Allylamines
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2019-2025)
8.4.4.3 Forecast Trend (2026-2035)
8.4.4.3.1 Terbinafine
8.4.4.3.2 Others
8.4.5 Others
8.5 Latin America Antifungal Drugs Market by Indication
8.5.1 Dermatophytosis
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2019-2025)
8.5.1.3 Forecast Trend (2026-2035)
8.5.2 Aspergillosis
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2019-2025)
8.5.2.3 Forecast Trend (2026-2035)
8.5.3 Candidiasis
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2019-2025)
8.5.3.3 Forecast Trend (2026-2035)
8.5.3.3.1 Invasive Candidiasis
8.5.3.3.2 Vulvovaginal Candidiasis (VVC)
8.5.3.3.3 Mouth/Throat/Esophageal Candidiasis
8.5.3.3.4 Others
8.5.4 Others
8.6 Latin America Antifungal Drugs Market by Country
8.7.1 Market Share
8.6.1.1 Brazil
8.6.1.2 Mexico
8.6.1.3 Argentina
8.6.1.4 Chile
8.6.1.5 Others
9 Regional Analysis
9.1 Brazil
9.1.1 Historical Trend (2019-2025)
9.1.2 Forecast Trend (2026-2035)
9.2 Mexico
9.2.1 Historical Trend (2019-2025)
9.2.2 Forecast Trend (2026-2035)
9.3 Argentina
9.3.1 Historical Trend (2019-2025)
9.3.2 Forecast Trend (2026-2035)
9.4 Chile
9.4.1 Historical Trend (2019-2025)
9.4.2 Forecast Trend (2026-2035)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyers Powers
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Key Company Profiles
11.2.1 Company Overview
11.2.2 Product Portfolio
11.2.3 Demographic Reach and Achievements
11.2.4 Certifications
12 Industry Events and Developments